Status:

COMPLETED

Treatment-Resistant Depression Registry

Lead Sponsor:

Cyberonics, Inc.

Conditions:

Major Depressive Disorder

Eligibility:

All Genders

18+ years

Brief Summary

This registry will collect information about patients with treatment-resistant depression (TRD) who are currently in a major depressive episode. For the purposes of this study, TRD is defined as an on...

Detailed Description

Enrollment of TRD patients treated with VNS Therapy will consist of patients originally enrolled in the registry as well as patients who have completed the D-21 Dosing Study and are enrolled in the Re...

Eligibility Criteria

Inclusion

  • Patient diagnosed with a current major depressive episode according to DSM-IV-TR criteria.
  • For D-21 patients only who have completed the D-21 dosing Study without any D-21 inclusion and exclusion protocol deviation.
  • Patient has been in the current depressive episode for 2 years or longer, or has had at least 3 lifetime episodes including the current MDE.
  • Patient has had an inadequate response to 4 or more adequate antidepressive treatments.
  • The patient has a CGI severity of illness score of moderately ill (score of 4) or greater.
  • The patient must be able to provide informed consent and complete all forms.

Exclusion

  • Patient has a history of schizophrenia, schizoaffective disorder, any other psychotic disorder, or a current major depressive episode that includes psychotic features; or is currently psychotic.
  • Patient is currently enrolled in a double blind investigational study; patients who have completed the double-blind D-21 study will be allowed to enter the Registry for Long Term Follow-up
  • Other than those patients who were enrolled in the D-21 study, patient has previously received VNS therapy.
  • Patient has a history of rapid cycling bipolar disorder.

Key Trial Info

Start Date :

January 1 2006

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2015

Estimated Enrollment :

795 Patients enrolled

Trial Details

Trial ID

NCT00320372

Start Date

January 1 2006

End Date

May 1 2015

Last Update

December 23 2015

Active Locations (55)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 14 (55 locations)

1

University of Arizona

Tucson, Arizona, United States, 85724

2

Cedars-Sinai Hospital

Beverly Hills, California, United States

3

Mark Zetin, MD - Private Practice

Garden Grove, California, United States, 92840

4

Loma Linda University

Loma Linda, California, United States